FdaApplication
NDA 208374
Identifiers
- fda_app_no: NDA208374
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | NDA |
| approval_date | 2017-12-21 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BIVALIRUDIN IN 0.9% SODIUM CHLORIDE | BIVALIRUDIN | 500MG/100ML (5MG/ML) | SOLUTION;INTRAVENOUS |
| BIVALIRUDIN IN 0.9% SODIUM CHLORIDE | BIVALIRUDIN | 250MG/50ML (5MG/ML) | SOLUTION;INTRAVENOUS |
2 products